Sustained ADAMTS13 deficiency may be seen without an acute TTP episode, but the potential consequences of chronic sub-normal ADAMTS13 activity levels on longer term health and risk are not clear. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.